Fort Washington Investment Advisors Inc. OH Sells 51,010 Shares of COPT Defense Properties $CDP

Fort Washington Investment Advisors Inc. OH trimmed its position in COPT Defense Properties (NYSE:CDPFree Report) by 5.0% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 966,850 shares of the company’s stock after selling 51,010 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in COPT Defense Properties were worth $29,586,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of COPT Defense Properties by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 17,127,858 shares of the company’s stock valued at $476,154,000 after acquiring an additional 128,583 shares during the period. Alliancebernstein L.P. increased its position in COPT Defense Properties by 16.8% during the third quarter. Alliancebernstein L.P. now owns 8,457,373 shares of the company’s stock worth $245,771,000 after acquiring an additional 1,215,936 shares during the period. JPMorgan Chase & Co. raised its stake in COPT Defense Properties by 8.3% in the 4th quarter. JPMorgan Chase & Co. now owns 3,862,294 shares of the company’s stock worth $107,372,000 after purchasing an additional 296,221 shares in the last quarter. Geode Capital Management LLC raised its stake in COPT Defense Properties by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,149,130 shares of the company’s stock worth $87,558,000 after purchasing an additional 17,049 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in COPT Defense Properties by 5.4% in the 2nd quarter. Bank of America Corp DE now owns 2,577,065 shares of the company’s stock valued at $71,075,000 after purchasing an additional 131,287 shares during the period.

COPT Defense Properties Trading Down 0.2%

CDP opened at $36.25 on Monday. COPT Defense Properties has a twelve month low of $26.91 and a twelve month high of $36.39. The company has a 50-day simple moving average of $32.60 and a 200 day simple moving average of $31.36. The company has a quick ratio of 2.85, a current ratio of 2.85 and a debt-to-equity ratio of 1.63. The stock has a market capitalization of $4.11 billion, a price-to-earnings ratio of 26.27 and a beta of 0.79.

COPT Defense Properties (NYSE:CDPGet Free Report) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.34). COPT Defense Properties had a return on equity of 10.02% and a net margin of 20.10%.The firm had revenue of $200.64 million for the quarter, compared to analyst estimates of $185.10 million. During the same quarter in the previous year, the company earned $0.65 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. Analysts predict that COPT Defense Properties will post 2.78 EPS for the current fiscal year.

COPT Defense Properties Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Tuesday, June 30th will be given a dividend of $0.32 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.28 annualized dividend and a dividend yield of 3.5%. COPT Defense Properties’s dividend payout ratio (DPR) is currently 92.75%.

Insider Activity

In related news, Director Robert L. Denton sold 3,922 shares of COPT Defense Properties stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $32.38, for a total value of $126,994.36. Following the transaction, the director directly owned 3,803 shares of the company’s stock, valued at $123,141.14. This trade represents a 50.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CDP. JPMorgan Chase & Co. increased their target price on shares of COPT Defense Properties from $33.00 to $34.00 and gave the stock a “neutral” rating in a research report on Friday, May 15th. Truist Financial lifted their price target on shares of COPT Defense Properties from $33.00 to $34.00 and gave the company a “hold” rating in a research report on Monday, June 8th. Evercore reiterated an “outperform” rating and issued a $38.00 price target on shares of COPT Defense Properties in a research note on Tuesday, April 28th. Cantor Fitzgerald reissued an “overweight” rating and set a $37.00 price target on shares of COPT Defense Properties in a research report on Thursday. Finally, Wells Fargo & Company raised their price objective on COPT Defense Properties from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $35.00.

View Our Latest Report on COPT Defense Properties

About COPT Defense Properties

(Free Report)

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.

Recommended Stories

Want to see what other hedge funds are holding CDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for COPT Defense Properties (NYSE:CDPFree Report).

Institutional Ownership by Quarter for COPT Defense Properties (NYSE:CDP)

Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.